Biomarkers for psychosis and their genetic importance is a research project led by Dr Elvira Bramon that aims to identify new biomarkers and genetic risk factors for psychotic disorders. The project examines families affected by psychotic conditions, such as schizophrenia and bipolar disorders. We study cognitive dysfunction, and functional and structural brain changes, in both patients and healthy relatives, and seek to relate these measures with genetic variants identified in the affected individuals.
This project is funded by the Medical Research Council (MRC) and the Wellcome Trust.
